Approval number 10mg Zhunzi H20023426.
Approval No. 20mg Zhunzi H37022369 Medicare B (602) based drugs.
Indications: for peptic ulcer (stomach, duodenal ulcer), reflux esophagitis and Zhuo-Ehrlich syndrome (gastrinoma).
Specifications: 10mg ⅹ 12 tablets 20mg ⅹ 7 tablets.
10mg ⅹ 48 tablets 20mg ⅹ 14 tablets.
